Proteogenomic Analysis of Surgically Resected Lung Adenocarcinoma.

ABSTRACT:

Introduction

Despite apparently complete surgical resection, approximately half of resected early-stage lung cancer patients relapse and die of their disease. Adjuvant chemotherapy reduces this risk by only 5% to 8%. Thus, there is a need for better identifying who benefits from adjuvant therapy, the drivers of relapse, and novel targets in this setting.

Methods

RNA sequencing and liquid chromatography/liquid chromatography-mass spectrometry proteomics data were generated from 51 surgically resected non-small cell lung tumors with known recurrence status.

Results

We present a rationale and framework for the incorporation of high-content RNA and protein measurements into integrative biomarkers and show the potential of this approach for predicting risk of recurrence in

SUBMITTER: Sharpnack MF 

PROVIDER: S-EPMC7135954 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature